In-vitro and In-silico modelling might be of great use is for known problems that come up for candidate drugs in the early clinical phase: Interaction with rece

In-vitro and In-silico modelling might be of great use is for known problems that come up for candidate drugs in the early clinical phase: Interaction with receptors (blood/brain barrier, QT prolongation etc) or liver proteins or the like. Of course, we are talking about the fruits on the drug tree which are potentially reachable by singular small molecule drugs.